Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab Announces National Medical Products Administration (Nmpa) Approval Of Augtyro™

Jan 6 (Reuters) - Zai Lab Ltd 9688.HK:

ZAI LAB ANNOUNCES NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) APPROVAL OF AUGTYRO™ (REPOTRECTINIB) FOR PATIENTS WITH NTRK-POSITIVE SOLID TUMORS

Source text: ID:nBw5p6pKJa

Further company coverage: 9688.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zai Lab

See all news